Latest News and Press Releases
Want to stay updated on the latest news?
-
GLEN ALLEN, Va., May 15, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies...
-
TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the “Corporation” or “Dundee”) today announced its financial results for the three months ended March 31, 2024. All currency...
-
TORONTO, May 10, 2024 (GLOBE NEWSWIRE) -- Further to its news releases dated February 14 and April 30, 2024, Copper Road Resources Inc. (TSXV: CRD, OTCQB: SAGGF) (“Copper Road” or the “Company”) is...
-
Detroit, MI, May 09, 2024 (GLOBE NEWSWIRE) -- College for Creative Studies (CCS) is pleased to welcome Ralph Gilles, Stellantis Chief Design Officer, as the honorary degree recipient and...
-
TicketSmarter announced its new Free Tickets for Life Sweepstakes which selects one lucky winner each month.
-
MONTRÉAL, 09 mai 2024 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou la « Société »), une société pharmaceutique spécialisée panaméricaine (à l’exclusion des É.-U.) de...
-
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial...
-
Record $150 billion of Deployable Capital Today Distributable Earnings of $4.9 billion and Net Income of $5.2 billion for the Last Twelve Months BROOKFIELD, NEWS, May 09, 2024 (GLOBE NEWSWIRE) --...
-
MONTRÉAL, 08 mai 2024 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou la « Société »), société pharmaceutique spécialisée panaméricaine (hors États-Unis) et chef de...
-
The CEOs of Golden Matrix and Meridianbet discuss acquisition benefits, corporate moat and growth strategies in IPO Edge Fireside Chat